News: Ben Venue Halts All Production at Ohio Plant

A troubled contract manufacturer, whose problems caused a shortage of Johnson & Johnson's cancer drug Doxil, has suspended manufacturing and distribution of products from its Ohio plant, saying routine preventive maintenance and other required actions were overdue.
Nov. 28, 2011
Sign up for our eNewsletters
Get the latest news and updates